ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 570,40
-0,82%
Dow Jones
40 211,72
0,00%
DAX
18 483,98
-0,62%
Brent Oil
82,965
-1,63%
Bitcoin
63 763,88
-1,68%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
11/06/202013h17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:TEVATeva Pharmaceutical Industries Ltd
11/06/202013h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
09/06/202013h30GlobeNewswire Inc.NIRI Philadelphia Elects New Board MembersNYSE:TEVATeva Pharmaceutical Industries Ltd
02/06/202014h00Business WireTeva Showcases Global Impact in 2019 Environmental, Social and Governance Progress ReportNYSE:TEVATeva Pharmaceutical Industries Ltd
26/05/202014h00Business WireTeva Announces Virtual 2020 Annual Meeting of ShareholdersNYSE:TEVATeva Pharmaceutical Industries Ltd
25/05/202019h08Business WireTeva präsentiert auf dem Kongress der Europäischen Akademie für Neurologie neue Daten zur Evaluierung der Erfahrungen von ...NYSE:TEVATeva Pharmaceutical Industries Ltd
25/05/202016h53Business WireTeva a présenté de nouvelles données lors du congrès de l'Académie européenne de neurologie évaluant l'expérience de ...NYSE:TEVATeva Pharmaceutical Industries Ltd
25/05/202008h00Business WireTeva Presented New Data at the European Academy of Neurology Congress Evaluating the AJOVY® (fremanezumab) Experience in Pop...NYSE:TEVATeva Pharmaceutical Industries Ltd
22/05/202020h11Business WireTeva präsentiert neue Analysen zu AJOVY® (Fremanezumab) und jüngste Daten zu COPAXONE® (Injektionslösung Glatirameraceta...NYSE:TEVATeva Pharmaceutical Industries Ltd
22/05/202018h11Business WireTeva va présenter de nouvelles analyses d'AJOVY® (fremanezumab) et les dernières données sur le COPAXONE® (acétate de g...NYSE:TEVATeva Pharmaceutical Industries Ltd
22/05/202008h00Business WireTeva to Present New AJOVY® (fremanezumab) Analyses & Latest COPAXONE® Data (glatiramer acetate injection) at European Acade...NYSE:TEVATeva Pharmaceutical Industries Ltd
18/05/202013h00Business WireChina Approves AUSTEDO® For Treating Chorea Associated with Huntington's Disease and Tardive Dyskinesia in AdultsNYSE:TEVATeva Pharmaceutical Industries Ltd
07/05/202013h00Business WireTeva Reports First Quarter 2020 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
04/05/202014h00Business WireTeva & Celltrion Healthcare Announce the Launch of TRUXIMA® (rituximab-abbs) Injection for Rheumatoid Arthritis, the Only Bi...NYSE:TEVATeva Pharmaceutical Industries Ltd
01/05/202014h00Business WireNew Data For Teva AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tablets Included in NeurologyNYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/202014h44Dow Jones NewsEagle Pharma, Teva Pharma Win Patent Decision for BendekaNYSE:TEVATeva Pharmaceutical Industries Ltd
27/04/202014h00Business WireTeva Announces U.S. Launch of Autoinjector for AJOVY® (fremanezumab-vfrm) InjectionNYSE:TEVATeva Pharmaceutical Industries Ltd
17/04/202000h27Business WireTeva to Host Conference Call to Discuss First Quarter 2020 Financial Results at 8 a.m. ET on May 7, 2020NYSE:TEVATeva Pharmaceutical Industries Ltd
07/04/202013h30PR Newswire (Canada)L'engagement de Teva Canada envers les proches aidants canadiensNYSE:TEVATeva Pharmaceutical Industries Ltd
07/04/202013h30PR Newswire (Canada)Teva Canada Committed to Canadian CaregiversNYSE:TEVATeva Pharmaceutical Industries Ltd
20/03/202001h23Business WireTeva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals NationwideNYSE:TEVATeva Pharmaceutical Industries Ltd
16/03/202013h00Business WireTeva and Celltrion Healthcare Announce U.S. Availability of HERZUMA® (trastuzumab-pkrb) for InjectionNYSE:TEVATeva Pharmaceutical Industries Ltd
12/03/202017h14Business WireAvis favorable de l'Institut national pour l'excellence clinique (NICE) pour le premier traitement anti-PRGC de la migraine :...NYSE:TEVATeva Pharmaceutical Industries Ltd
12/03/202017h03Business WirePositive Empfehlung des NICE für die erste, gegen das CGRP gerichtete Migränetherapie: AJOVY®▼ (Fremanezumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
12/03/202008h30Business WirePositive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®▼ (fremanezumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
24/02/202015h13Dow Jones NewsTeva Gets FDA Approval for ArmonAir Digihaler Inhalation PowderNYSE:TEVATeva Pharmaceutical Industries Ltd
24/02/202014h00Business WireTeva Announces FDA Approval of ArmonAir® Digihaler™ (fluticasone propionate) Inhalation PowderNYSE:TEVATeva Pharmaceutical Industries Ltd
19/02/202022h05Business WireTeva Announces Registration Trials of Deutetrabenazine in Pediatric Patients with Tourette Syndrome Did Not Meet the Primary ...NYSE:TEVATeva Pharmaceutical Industries Ltd
12/02/202013h30Business WireNew Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 BillionNYSE:TEVATeva Pharmaceutical Industries Ltd
12/02/202013h00Business WireTeva Reports Fourth Quarter and Full Year 2019 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
BEL20
Bel 20
EU
GLE
Societe Generale
EU
ACA
Credit Agricole
EU
AF
Air FranceKLM
EU
PX4
SBF 120
EU
BNP
BNP Paribas
COIN
ETHUSD
Ethereum
NYSE
DIS
Walt Disney
EU
VK
Vallourec
NYSE
MRK
Merck
EU
ML
Michelin
EU
ORA
Orange
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés